A Carbocyclic Nucleoside Analogue Is a TNF-α Inhibitor with Immunosuppressive Action: Role of Prostaglandin E2and Protein Kinase C and Comparison with Pentoxifylline

This publication has 22 references indexed in Scilit:

• Inhibition Of The Effects Of Tnf In Renal Allograft Recipients Using Recombinant Human Dimeric Tumor Necrosis Factor Receptors
  Transplantation, 1995
• HLA class II molecule‐mediated signal transduction mechanism responsible for the expression of interleukin‐1β and tumor necrosis factor‐α genes induced by a staphylococcal superantigen
  European Journal of Immunology, 1993
• EVIDENCE THAT ANTIHUMAN TUMOR NECROSIS FACTOR MONOCLONAL ANTIBODY PREVENTS OKT3-INDUCED ACUTE SYNDROME
  Transplantation, 1992
• The Pathophysiology of Tumor Necrosis Factors
  Annual Review of Immunology, 1992
• Macrophage priming and lipopolysaccharide-triggered release of tumor necrosis factor alpha during graft-versus-host disease.
  The Journal of Experimental Medicine, 1992
• Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectin/tumor necrosis factor synthesis at separate points in the signaling pathway.
  The Journal of Experimental Medicine, 1990
• Cyclosporine a inhibits TNF production without decreasing TNF mRNA levels
  Biochemical and Biophysical Research Communications, 1989
• Cellular and molecular regulation of tumor necrosis factor-alpha production by pentoxofylline
  Biochemical and Biophysical Research Communications, 1988
• Tumor necrosis factor/cachectin is an effector of skin and gut lesions of the acute phase of graft-vs.-host disease.
  The Journal of Experimental Medicine, 1987
• Raised serum levels of cachectin/tumor necrosis factor alpha in renal allograft rejection.
  The Journal of Experimental Medicine, 1987